JP2009519232A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009519232A5 JP2009519232A5 JP2008542430A JP2008542430A JP2009519232A5 JP 2009519232 A5 JP2009519232 A5 JP 2009519232A5 JP 2008542430 A JP2008542430 A JP 2008542430A JP 2008542430 A JP2008542430 A JP 2008542430A JP 2009519232 A5 JP2009519232 A5 JP 2009519232A5
- Authority
- JP
- Japan
- Prior art keywords
- expression
- macroglobulin
- gene
- expression level
- intraocular pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000014509 gene expression Effects 0.000 claims 23
- 102100033312 Alpha-2-macroglobulin Human genes 0.000 claims 12
- 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 claims 12
- 108090000623 proteins and genes Proteins 0.000 claims 10
- 239000000203 mixture Substances 0.000 claims 8
- 230000004410 intraocular pressure Effects 0.000 claims 7
- 238000000034 method Methods 0.000 claims 7
- 210000003994 retinal ganglion cell Anatomy 0.000 claims 7
- 230000000694 effects Effects 0.000 claims 6
- 206010030043 Ocular hypertension Diseases 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 208000010412 Glaucoma Diseases 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 4
- 210000001742 aqueous humor Anatomy 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 230000001684 chronic effect Effects 0.000 claims 3
- 230000007850 degeneration Effects 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 230000001105 regulatory effect Effects 0.000 claims 3
- 108060003345 Adrenergic Receptor Proteins 0.000 claims 2
- 102000017910 Adrenergic receptor Human genes 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108020000948 Antisense Oligonucleotides Proteins 0.000 claims 1
- 102000001851 Low Density Lipoprotein Receptor-Related Protein-1 Human genes 0.000 claims 1
- 108020004459 Small interfering RNA Proteins 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 239000000048 adrenergic agonist Substances 0.000 claims 1
- 230000003042 antagnostic effect Effects 0.000 claims 1
- 239000000074 antisense oligonucleotide Substances 0.000 claims 1
- 238000012230 antisense oligonucleotides Methods 0.000 claims 1
- NWIUTZDMDHAVTP-UHFFFAOYSA-N betaxolol Chemical compound C1=CC(OCC(O)CNC(C)C)=CC=C1CCOCC1CC1 NWIUTZDMDHAVTP-UHFFFAOYSA-N 0.000 claims 1
- 229960004324 betaxolol Drugs 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 101150084157 lrp-1 gene Proteins 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 230000003547 miosis Effects 0.000 claims 1
- 239000003604 miotic agent Substances 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 claims 1
- 239000000816 peptidomimetic Substances 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 150000003180 prostaglandins Chemical class 0.000 claims 1
- 239000004055 small Interfering RNA Substances 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 239000013598 vector Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73957005P | 2005-11-22 | 2005-11-22 | |
| US60/739,570 | 2005-11-22 | ||
| PCT/US2006/045169 WO2007062101A2 (en) | 2005-11-22 | 2006-11-22 | Intraocular pressure-regulated early genes and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009519232A JP2009519232A (ja) | 2009-05-14 |
| JP2009519232A5 true JP2009519232A5 (cg-RX-API-DMAC7.html) | 2011-09-15 |
| JP5249774B2 JP5249774B2 (ja) | 2013-07-31 |
Family
ID=38067890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008542430A Expired - Fee Related JP5249774B2 (ja) | 2005-11-22 | 2006-11-22 | 眼内圧調節初期遺伝子およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8563520B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1957986B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5249774B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101360999B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006318550A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2630668C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007062101A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0634001Y2 (ja) | 1989-02-02 | 1994-09-07 | 石川島播磨重工業株式会社 | 水平対向型幅プレスの金型取付装置 |
| AU2006318550A1 (en) * | 2005-11-22 | 2007-05-31 | Mcgill University | Intraocular pressure-regulated early genes and uses thereof |
| US8648169B2 (en) | 2006-12-05 | 2014-02-11 | The Royal Institution For The Advancement Of Learning/Mcgill University | Methods of use of Trk receptor modulators |
| WO2010118340A1 (en) * | 2009-04-09 | 2010-10-14 | University Of Medicine And Dentistry Of New Jersey | Treatment of cutaneous hemangioma |
| CN102210851A (zh) * | 2011-05-31 | 2011-10-12 | 中国人民解放军第三军医大学第一附属医院 | 人αB-晶体蛋白在制备保护视网膜神经节细胞的药物中的应用 |
| US20140228299A1 (en) * | 2011-09-20 | 2014-08-14 | National University Corporation Tokyo Medical And Dental University | Prophylactic and therapeutic agent for neurological diseases using lipoproteins and prophylactic and therapeutic method for neurological diseases |
| EP3140422A1 (en) * | 2014-05-03 | 2017-03-15 | The Regents of The University of California | Methods of identifying biomarkers associated with or causative of the progression of disease, in particular for use in prognosticating primary open angle glaucoma |
| US20180021404A1 (en) * | 2015-02-20 | 2018-01-25 | The Regents Of The University Of California | Methods and compositions for treating glaucoma |
| JP7033840B2 (ja) * | 2016-06-17 | 2022-03-11 | ユーロイミューン・メディツィニシェ・ラボルディアグノシュティカ・アクチエンゲゼルシャフト | 神経自己免疫疾患の診断 |
| CN106434933A (zh) * | 2016-10-11 | 2017-02-22 | 青岛大学 | Crybb2基因在制备检测先天性白内障制品中的应用 |
| US12606868B2 (en) | 2020-02-24 | 2026-04-21 | The Board Of Regents Of The University Of Texas System | Molecular biomarkers and targets for Fuchs' endothelial corneal dystrophy and glaucoma |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) * | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| CN2237430Y (zh) * | 1995-07-20 | 1996-10-16 | 北京市橡胶制品设计研究院 | 青光眼房水引流盘 |
| US6441047B2 (en) * | 1995-11-17 | 2002-08-27 | Alcon Manufacturing Ltd.. | Combination therapy for treating glaucoma |
| US6482854B1 (en) * | 1999-03-25 | 2002-11-19 | Massachusetts Eye And Ear Infirmary | Glaucoma treatment |
| DE10305212A1 (de) * | 2003-02-07 | 2004-08-19 | Florian Prof. Dr.med. Lang | Verwendung der sgk-Genfamilie zur Diagnose und zur Therapie von Katarakt und Glaukom |
| TWI398261B (zh) * | 2003-12-17 | 2013-06-11 | Alcon Inc | 血清類澱粉a基因於診斷及治療青光眼及鑑定抗青光眼劑上之用途 |
| DE602005012812D1 (de) * | 2005-06-13 | 2009-04-02 | Primm Srl | Heterodimere Peptide mit NGF Aktivität und deren Verwendung zur Behandlung von neurodegenerativen Krankheiten |
| AU2006318550A1 (en) * | 2005-11-22 | 2007-05-31 | Mcgill University | Intraocular pressure-regulated early genes and uses thereof |
| EP1921087A1 (en) | 2006-11-10 | 2008-05-14 | Primm S.R.L. | Process for the preparation of cyclic peptides |
-
2006
- 2006-11-22 AU AU2006318550A patent/AU2006318550A1/en not_active Abandoned
- 2006-11-22 CN CN2006800515976A patent/CN101360999B/zh not_active Expired - Fee Related
- 2006-11-22 EP EP06844496.7A patent/EP1957986B1/en active Active
- 2006-11-22 CA CA2630668A patent/CA2630668C/en active Active
- 2006-11-22 WO PCT/US2006/045169 patent/WO2007062101A2/en not_active Ceased
- 2006-11-22 JP JP2008542430A patent/JP5249774B2/ja not_active Expired - Fee Related
-
2008
- 2008-05-22 US US12/154,396 patent/US8563520B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma | |
| Adams et al. | Glaucoma-Next Generation Therapeutics: Impossible to Possible: Adams et al. | |
| JP2024069452A (ja) | ドライアイの治療用医薬組成物 | |
| CA2536912C (en) | Combination therapy for the treatment of ocular neovascular disorders | |
| EP2803357B1 (en) | Angiogenesis inhibitors | |
| Ranta et al. | Barrier analysis of periocular drug delivery to the posterior segment | |
| CA2749537C (en) | Il-1 antagonist compositions for corneal nerve regeneration and protection | |
| EP4374873A2 (en) | Methods for treating or preventing opthalmological conditions | |
| Bucolo et al. | Dopamine-3 receptor modulates intraocular pressure: implications for glaucoma | |
| WO2008154482A2 (en) | Sirna compositions and methods of use in treatment of ocular diseases | |
| US20180221339A1 (en) | Compositions and methods for treating and diagnosing ocular disorders | |
| Whitlock et al. | Decreased intraocular pressure in mice following either pharmacological or genetic inhibition of ROCK | |
| Hudson et al. | Indirect sympatholytic actions at β-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonists | |
| US20120014970A1 (en) | Therapeutic Compositions for Treatment of Corneal Disorders | |
| Ruan et al. | Adrenoceptors in the eye–physiological and pathophysiological relevance | |
| US10011837B2 (en) | SiRNAs and their use in methods and compositions for the treatment and/or prevention of eye conditions | |
| US20140315811A1 (en) | Ophthalmic preparations based on pacap (pituitary adenylate cyclase activating polypeptide) which restore the normal visual function in early glaucoma | |
| US10011832B2 (en) | SiRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions | |
| Adams et al. | Recent developments for the treatment of glaucoma | |
| KR102775781B1 (ko) | Acta2 억제제를 유효성분으로 포함하는 망막 또는 맥락막 질환 치료용 조성물 | |
| JP2008542385A (ja) | 神経損傷の抑制 | |
| Crowston et al. | Prostaglandin FP receptors do not contribute to 24-hour intraocular pressure variation in mice | |
| Chen et al. | The biomechanical properties of the cornea of patients with glaucoma treated with anti-glaucoma topical medications | |
| JP2017200928A (ja) | siRNAならびに眼の状態の処置および/または予防のための方法および組成物におけるその使用 | |
| MXPA06002293A (en) | Combination therapy for the treatment of ocular neovascular disorders |